rtx1 users’ e-symposium 2022

Imagine Eyes organized a rtx1 users’ e-symposium on May 30th, 2022, at 4pm CEST. In a 90min meeting, users of Imagine Eyes’ adaptive optics (AO) technology shared about their experience with cellular and microvascular retinal imaging in clinical settings.

This symposium was chaired by Prof. Paulo E. Stanga and Dr. Daniela Bacherini. Several participants presented recent progress made with rtx1 AO cameras (results of clincial studies and case reports) as well as an update on ongoing technology developments at Imagine Eyes. There was time for questions and discussions as well.





4:00pm CEST – Welcome

4:02pm CEST – Session 1 – rtx1 in Retinitis Pigmentosa

  • AO ophthalmoscopy in RP: typical patterns. Friederike Kortuem, University Hospital of Tuebingen (GER)
  • Photoreceptor features in RP with macular edema using AO fundus camera. Shohei Kitahata, Department of Ophthalmology and Micro-technology, Yokohama City University (JP)
  • Early detection of localized cone loss in female carriers of RPGR mutations using adaptive optics imaging. Danial Roshandel, Lions Eye Institute, Perth (AUS)
  • Q&A discussion

4:25pm CEST – Session 2 – Case reports

  • Acute macular neuroretinopathy. Toshio Mori, Nagoya Chukyo Hospital (JP)
  • Puffy cones. Hassan Khojasteh, Byers Eye Institute, Stanford University (USA)
  • AO and multimodal imaging follow-up of CSR with RPE changes. Ursula Reinstein, The Retina Clinic London (UK)
  • AO in syphilitic retinopathy. Stefano Mercuri, AOU Careggi Teaching Hospital, Florence (IT)
  • Q&A discussion

4:43pm CEST – Session 3 – Ongoing technology developments

  • What’s coming in rtx1? Marine Durand, Imagine Eyes (FR)
  • Multimodal multiscale imaging – first clinical results. Kiyoko Gocho, Quinze-Vingts National Eye Hospital (FR)
  • Q&A discussion

5:01pm CEST – Session 4 – rtx1 in AMD, diabetes and inflammation

  • AO phenotypes in intermediate AMD. Sobha Sivaprasad, Moorfields Eye Hospital, London (UK)
  • Enhanced visualization and progression tracking of gaze dependent features in AOO. Nathaniel Norberg, Quinze-Vingts National Eye Hospital, Paris (FR)
  • Microvascular features on AO imaging in diabetes. Irina-Elena Cristescu, Retina Clinic, Bucharest (ROM)
  • AO and multimodal imaging for inflammatory vitreoretinal interface abnormalities. Marie-Hélène Errera, University of Pittsburgh School of Medicine (US)
  • Q&A discussion

5:30pm CEST – Concluding remarks